Preventive Cardiology & Population Health

Focuses on strategies to mitigate cardiovascular risk factors across global populations before clinical disease manifests.

Sub-topics:

• Lifetime exposure risk of LDL cholesterol and novel lipid-lowering agents (e.g., siRNA therapies, PCSK9 inhibitors)

• Addressing global tobacco control, vaping, and environmental cardiotoxins (e.g., air pollution)

• Population-wide dietary interventions and primordial prevention strategies in low- and middle-income regions